Norio Doi

631 total citations
20 papers, 389 citations indexed

About

Norio Doi is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Norio Doi has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Norio Doi's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (8 papers) and Cancer therapeutics and mechanisms (5 papers). Norio Doi is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (8 papers) and Cancer therapeutics and mechanisms (5 papers). Norio Doi collaborates with scholars based in Japan, Thailand and Switzerland. Norio Doi's co-authors include Areeya Disratthakit, Yuko Kazumi, Shinji Maeda, Hitoshi Hotoda, Masayo Kakuta, Naotoshi Yamamura, Angkana Chaiprasert, Tetsufumi Koga, Therdsak Prammananan and Yasunori Muramatsu and has published in prestigious journals such as The Journal of Immunology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Norio Doi

19 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norio Doi Japan 10 256 199 157 65 56 20 389
Suresh B. Lakshminarayana Singapore 12 333 1.3× 216 1.1× 196 1.2× 110 1.7× 40 0.7× 15 573
Mariama C. Maiga United States 9 280 1.1× 168 0.8× 169 1.1× 31 0.5× 62 1.1× 10 384
Lisa K. Woolhiser United States 15 363 1.4× 230 1.2× 255 1.6× 127 2.0× 55 1.0× 18 634
A. Koul United States 4 370 1.4× 303 1.5× 142 0.9× 35 0.5× 52 0.9× 6 445
Michelle S DeStefano United States 12 358 1.4× 293 1.5× 151 1.0× 56 0.9× 51 0.9× 20 532
H. M. Adnan Hameed China 13 354 1.4× 250 1.3× 259 1.6× 81 1.2× 57 1.0× 29 532
Elizabeth J. Brooks United States 11 343 1.3× 270 1.4× 129 0.8× 40 0.6× 34 0.6× 11 526
Peter C. Ray United Kingdom 12 284 1.1× 179 0.9× 256 1.6× 162 2.5× 52 0.9× 21 556
Mel Spigelman United States 6 272 1.1× 171 0.9× 142 0.9× 57 0.9× 24 0.4× 11 376
Meenakshi Balganesh India 11 332 1.3× 250 1.3× 205 1.3× 54 0.8× 126 2.3× 17 474

Countries citing papers authored by Norio Doi

Since Specialization
Citations

This map shows the geographic impact of Norio Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Doi more than expected).

Fields of papers citing papers by Norio Doi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Doi. The network helps show where Norio Doi may publish in the future.

Co-authorship network of co-authors of Norio Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Norio Doi. A scholar is included among the top collaborators of Norio Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norio Doi. Norio Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Disratthakit, Areeya, Therdsak Prammananan, Chanwit Tribuddharat, et al.. (2016). Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates. Antimicrobial Agents and Chemotherapy. 60(9). 5189–5197. 23 indexed citations
2.
Disratthakit, Areeya, et al.. (2015). Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand. Infection Genetics and Evolution. 32. 432–439. 23 indexed citations
3.
Maeda, Shinji, et al.. (2014). In Vitro Susceptibility of Mycobacterium tuberculosis Isolates to an Oral Carbapenem Alone or in Combination with β-Lactamase Inhibitors. Antimicrobial Agents and Chemotherapy. 58(11). 7010–7014. 36 indexed citations
4.
Iyoda, Takuya, Takuya Matsunaga, Kimiko Makino, et al.. (2014). A Novel Mechanism Underlying the Basic Defensive Response of Macrophages against Mycobacterium Infection. The Journal of Immunology. 192(9). 4254–4262. 7 indexed citations
5.
Doi, Norio, et al.. (2014). Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein. Antimicrobial Agents and Chemotherapy. 58(6). 3168–3176. 32 indexed citations
6.
Takahashi, Yoshiaki, Masayuki Igarashi, Toshiaki Miyake, et al.. (2013). Novel semisynthetic antibiotics from caprazamycins A–G: caprazene derivatives and their antibacterial activity. The Journal of Antibiotics. 66(3). 171–178. 62 indexed citations
7.
Sekiguchi, Jun‐ichiro, Areeya Disratthakit, Shinji Maeda, & Norio Doi. (2011). Characteristic Resistance Mechanism of Mycobacterium tuberculosis to DC-159a, a New Respiratory Quinolone. Antimicrobial Agents and Chemotherapy. 55(8). 3958–3960. 17 indexed citations
8.
Disratthakit, Areeya, Norio Doi, Mitsuko Takenaga, & Yuki Ohta. (2010). Anti-tuberculosis activity and drug interaction with nevirapine of inhalable lipid microspheres containing rifampicin in murine model. Journal of Microencapsulation. 27(4). 365–371. 1 indexed citations
9.
Duan, Hongfei, et al.. (2010). [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents].. PubMed. 33(5). 359–62. 1 indexed citations
10.
Disratthakit, Areeya & Norio Doi. (2010). In Vitro Activities of DC-159a, a Novel Fluoroquinolone, against Mycobacterium Species. Antimicrobial Agents and Chemotherapy. 54(6). 2684–2686. 37 indexed citations
11.
Doi, Norio. (2009). [New horizons of next generation chemotherapy for mycobacteriosis].. PubMed. 84(3). 133–40. 1 indexed citations
12.
Doi, Norio. (2008). Characterization of In Vivo Activity of Novel Anti-TB Drug Candidates OPC-67683 and PA-824 in Murine TB Models. 46th Annual Meeting. 1 indexed citations
13.
Takenaga, Mitsuko, et al.. (2008). Lipid Microsphere Formulation Containing Rifampicin Targets Alveolar Macrophages. Drug Delivery. 15(3). 169–175. 20 indexed citations
14.
Koga, Tetsufumi, Takashi Fukuoka, Norio Doi, et al.. (2004). Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo. Journal of Antimicrobial Chemotherapy. 54(4). 755–760. 76 indexed citations
15.
Igarashi, Masayuki, Naoko Nakagawa, Norio Doi, et al.. (2003). Caprazamycin B, a Novel Antituberculosis Antibiotic, from Streptomyces sp.. ChemInform. 34(48). 1 indexed citations
16.
Doi, Norio. (2002). Current status in the development of new anti-tuberculosis drugs. 50(11). 425–435.
17.
Doi, Norio, et al.. (1998). Effect of wood vinegar to fungus disease of silkworm, Bombyx mori. Nihon sanshigaku zasshi. 67(2). 143–145. 1 indexed citations
18.
Sugawara, Isamu, Hiroyuki Yamada, Yuko Kazumi, et al.. (1998). Induction of granulomas in interferon-  gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. Journal of Medical Microbiology. 47(10). 871–877. 46 indexed citations
19.
Doi, Norio. (1998). [Development of the intratracheal infection model of experimental murine mycobacteriosis: comparison with the intravenous infection model].. PubMed. 73(5). 339–47. 3 indexed citations
20.
Doi, Norio. (1986). Antituberculosis drugs. InPharma. 527(1). 2–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suresh B. Lakshminarayana Breakdown of academic impact, for papers by Mariama C. Maiga Breakdown of academic impact, for papers by Lisa K. Woolhiser Breakdown of academic impact, for papers by A. Koul Breakdown of academic impact, for papers by Michelle S DeStefano Breakdown of academic impact, for papers by H. M. Adnan Hameed Breakdown of academic impact, for papers by Elizabeth J. Brooks Breakdown of academic impact, for papers by Peter C. Ray Breakdown of academic impact, for papers by Mel Spigelman Breakdown of academic impact, for papers by Meenakshi Balganesh
Rankless by CCL
2026